BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 9346946)

  • 1. Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
    Dagoneau N; Scheffer D; Huber C; Al-Gazali LI; Di Rocco M; Godard A; Martinovic J; Raas-Rothschild A; Sigaudy S; Unger S; Nicole S; Fontaine B; Taupin JL; Moreau JF; Superti-Furga A; Le Merrer M; Bonaventure J; Munnich A; Legeai-Mallet L; Cormier-Daire V
    Am J Hum Genet; 2004 Feb; 74(2):298-305. PubMed ID: 14740318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant viral intergenic DNA sequence repeats with transcription enhancing activity.
    Velten J; Morey KJ; Cazzonelli CI
    Virol J; 2005 Feb; 2():16. PubMed ID: 15730562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of the enhancer-rich regulatory region of the gene for the cell-type specific transcription factor POU1F1.
    Wallis M; Xu Q; Krawczyk M; Skowronska-Krawczyk D
    Heliyon; 2024 Apr; 10(7):e28640. PubMed ID: 38590853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the human placental cysteine dioxygenase type 1 gene.
    Dawson PA; Weerasekera SJ; Atcheson RJ; Twomey SA; Simmons DG
    Mol Genet Metab Rep; 2020 Mar; 22():100568. PubMed ID: 32055444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription enhancer factor-5 and a GATA-like protein determine placental-specific expression of the Type I human 3beta-hydroxysteroid dehydrogenase gene, HSD3B1.
    Peng L; Huang Y; Jin F; Jiang SW; Payne AH
    Mol Endocrinol; 2004 Aug; 18(8):2049-60. PubMed ID: 15131259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional map of a placenta-specific enhancer of the human leukemia inhibitory factor receptor gene.
    Wang Z; Melmed S
    J Biol Chem; 1998 Oct; 273(40):26069-77. PubMed ID: 9748286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
    Mosley B; De Imus C; Friend D; Boiani N; Thoma B; Park LS; Cosman D
    J Biol Chem; 1996 Dec; 271(51):32635-43. PubMed ID: 8999038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of the soluble and membrane-bound forms of the murine leukemia inhibitory factor receptor alpha-chain. Expression in normal, gestating, and leukemia inhibitory factor nullizygous mice.
    Owczarek CM; Layton MJ; Robb LG; Nicola NA; Begley CG
    J Biol Chem; 1996 Mar; 271(10):5495-504. PubMed ID: 8621407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the mouse leukaemia inhibitory factor receptor gene: regulated expression of mRNA encoding a soluble receptor isoform from an alternative 5' untranslated region.
    Chambers I; Cozens A; Broadbent J; Robertson M; Lee M; Li M; Smith A
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):879-88. PubMed ID: 9396734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an upstream enhancer within a functional promoter of the human leukemia inhibitory factor receptor gene and its alternative promoter usage.
    Wang Z; Melmed S
    J Biol Chem; 1997 Oct; 272(44):27957-65. PubMed ID: 9346946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells.
    Tomida M
    Leuk Lymphoma; 2000 May; 37(5-6):517-25. PubMed ID: 11042511
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.